Reviva Pharmaceuticals Holdings, Inc.
RVPH
$0.68
-$0.01-1.41%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 22.19M | 14.44M | 13.18M | 10.36M | 5.29M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 1.37M | 664.70K | 329.70K | 451.40K | 967.90K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 23.56M | 15.10M | 13.51M | 10.82M | 6.26M |
|
|
|||||
| Total Current Assets | 23.56M | 15.10M | 13.51M | 10.82M | 6.26M |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | 819.70K | 819.70K | 819.70K | 819.70K |
| Total Assets | 23.56M | 15.92M | 14.33M | 11.63M | 7.08M |
|
|
|||||
| Total Accounts Payable | 2.09M | 3.01M | 5.43M | 4.97M | 4.72M |
| Total Accrued Expenses | 3.80M | 3.86M | 4.31M | 6.07M | 6.08M |
| Short-term Debt | 231.30K | 406.90K | -- | 113.20K | 224.30K |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | 922.60K | 482.90K |
| Total Other Current Liabilities | -- | -- | -- | 922.60K | 482.90K |
| Total Current Liabilities | 6.12M | 7.28M | 9.74M | 12.08M | 11.51M |
|
|
|||||
| Total Current Liabilities | 6.12M | 7.28M | 9.74M | 12.08M | 11.51M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 231.30K | 406.90K | -- | 113.20K | 224.30K |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | 44.50K | 16.70K | 27.80K |
| Total Liabilities | 6.12M | 7.28M | 9.78M | 12.09M | 11.54M |
|
|
|||||
| Common Stock & APIC | 204.77M | 192.79M | 185.32M | 176.30M | 166.25M |
| Retained Earnings | -187.33M | -184.14M | -180.77M | -176.76M | -170.71M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 17.44M | 8.65M | 4.55M | -459.10K | -4.46M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 17.44M | 8.65M | 4.55M | -459.10K | -4.46M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 17.44M | 8.65M | 4.55M | -459.10K | -4.46M |
|
|
|||||